Denali Capital Acquisition Corp. Class A
Why Robinhood?
You can watch DNQAF and buy or sell other stocks, ETFs, and their options commission-free!About DNQAF
Semnur Pharmaceuticals, Inc. engages in developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. It offers the product, SP-102, a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain.
DNQAF Key Statistics
Stock Snapshot
As of today, Denali Capital Acquisition Corp. Class A(DNQAF) shares are valued at $12.05. The company's market cap stands at 2.77B, with a P/E ratio of -8.12.
On 2026-05-02, Denali Capital Acquisition Corp. Class A(DNQAF) stock opened at —, reached a high of —, and a low of —.
The Denali Capital Acquisition Corp. Class A(DNQAF)'s current trading volume is 0, compared to an average daily volume of 53.1.
In the last year, Denali Capital Acquisition Corp. Class A(DNQAF) shares hit a 52-week high of $23.00 and a 52-week low of $4.50.
In the last year, Denali Capital Acquisition Corp. Class A(DNQAF) shares hit a 52-week high of $23.00 and a 52-week low of $4.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.